全文获取类型
收费全文 | 2589185篇 |
免费 | 206457篇 |
国内免费 | 4108篇 |
专业分类
耳鼻咽喉 | 36885篇 |
儿科学 | 87550篇 |
妇产科学 | 72691篇 |
基础医学 | 368430篇 |
口腔科学 | 73592篇 |
临床医学 | 230574篇 |
内科学 | 507774篇 |
皮肤病学 | 55394篇 |
神经病学 | 208758篇 |
特种医学 | 103257篇 |
外国民族医学 | 1067篇 |
外科学 | 395454篇 |
综合类 | 60350篇 |
现状与发展 | 4篇 |
一般理论 | 909篇 |
预防医学 | 200193篇 |
眼科学 | 59433篇 |
药学 | 194391篇 |
5篇 | |
中国医学 | 4795篇 |
肿瘤学 | 138244篇 |
出版年
2018年 | 26338篇 |
2016年 | 22261篇 |
2015年 | 25461篇 |
2014年 | 35441篇 |
2013年 | 53950篇 |
2012年 | 73667篇 |
2011年 | 77892篇 |
2010年 | 46231篇 |
2009年 | 43926篇 |
2008年 | 74080篇 |
2007年 | 78548篇 |
2006年 | 79351篇 |
2005年 | 77153篇 |
2004年 | 75310篇 |
2003年 | 72376篇 |
2002年 | 70713篇 |
2001年 | 119953篇 |
2000年 | 124366篇 |
1999年 | 105685篇 |
1998年 | 29419篇 |
1997年 | 26595篇 |
1996年 | 26825篇 |
1995年 | 25870篇 |
1994年 | 24373篇 |
1993年 | 22815篇 |
1992年 | 86157篇 |
1991年 | 84019篇 |
1990年 | 82185篇 |
1989年 | 78841篇 |
1988年 | 73134篇 |
1987年 | 72027篇 |
1986年 | 67980篇 |
1985年 | 65528篇 |
1984年 | 49144篇 |
1983年 | 42108篇 |
1982年 | 24732篇 |
1981年 | 22260篇 |
1980年 | 20585篇 |
1979年 | 46016篇 |
1978年 | 32106篇 |
1977年 | 27084篇 |
1976年 | 25484篇 |
1975年 | 27185篇 |
1974年 | 32735篇 |
1973年 | 31539篇 |
1972年 | 29001篇 |
1971年 | 26882篇 |
1970年 | 24984篇 |
1969年 | 23204篇 |
1968年 | 21198篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献84.
85.
86.
Amosova E. N. Shilova I. V. Zueva E. P. Rybalkina O. Yu. 《Pharmaceutical Chemistry Journal》2020,54(7):721-724
Pharmaceutical Chemistry Journal - Three extracts were produced from the above-ground part of the meadowsweet Filipendula ulmaria (L.) Maxim. using water, 40% ethanol, and 70% ethanol. Comparative... 相似文献
87.
88.
Olutobi Babatope Ojuawo Olufemi Olumuyiwa Desalu Ademola Emmanuel Fawibe Ayotade Boluwatife Ojuawo Adeniyi Olatunji Aladesanmi Christopher Muyiwa Opeyemi Mosunmoluwa Obafemi Adio Abdulraheem Olayemi Jimoh Dele Ohinoyi Amadu Abayomi Fadeyi Kazeem Alakija Salami 《African health sciences》2020,20(4):1655
BackgroundThe optimal management of community acquired pneumonia (CAP) depends on the clinical and microbiological profile in the locality.ObjectivesTo determine the clinical and microbiological profile of patients admitted with CAP in Ilorin, Nigeria.MethodsOne hundred and two consenting consecutively selected patients with clinical and radiologic confirmation of CAP were recruited in 12 months. The socio-demographic, physical examination and laboratory/radiologic parameters were documented in a questionnaire. Microbiological evaluation of their sputum was done and blood samples were taken for complete blood count, culture, serum urea and serological evaluation for atypical bacteria and some viral pathogens.ResultsCAP constituted 5.9% of the total medical admissions during the one-year study period. The mean age of the patients was 49 ± 22 years with the largest frequency in those aged 65 years and above. The commonest symptoms were shortness of breath (96.1%) and cough (94.1%), with a median duration of 3 days from symptom onset to admission. Systemic hypertension was the commonest comorbid illness (25/102; 24.5%). Klebsiella pneumoniae was the predominant pathogen isolated (20/102; 28.1%). The susceptible antibiotics were Imipenem, Ceftazidime and Ceftriaxone. Intra-hospital mortality was 17.6%. CURB – 65 score of ≥ 2 and the presence of complications of CAP were the independent predictors of mortality.ConclusionCAP constitutes a significant disease burden in Ilorin, Nigeria. Typical bacteria accounted for over half of the pathogens isolated from the patients with gram negative agents predominating. This highlights a possible shift in the microbiological profile which could guide empirical treatment. 相似文献
89.
Koel Dutt P N Agarwal Rajdeep Singh Vikas Singh Tomar 《The Indian journal of surgery》2015,77(1):62-64
Haemophilia is a common cause of genetically inherited bleeding disorders. Pseudotumours occur in 1–2 % of persons with severe forms of haemophilia. These are a result of repeated haemorrhage into soft tissues, subperiosteum or a site of bone fracture with inadequate resorption of the extravasated blood. There are a number of therapeutic alternatives for this dangerous condition: surgical removal, percutaneous management, irradiation, embolization etc. In this case report, we describe the natural history, clinical course and successful surgical management of a patient with haemophilia who presented with a massive pseudotumour. We also briefly review the relevant literature on the various therapeutic modalities that have been implemented in the management of this rare complication. Though surgeons may be averse to operate on haemophiliacs, primary surgical management as done in our case may prove to be the definitive treatment option for such patients. 相似文献